Alzheimer's & Dementia: The Journal of the Alzheimer's Association

Slides:



Advertisements
Similar presentations
2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.
Advertisements

Sleep disruption changes across the disease trajectory: Pilot findings from the healthy patterns sleep study Nancy A. Hodgson, Albert J. Safi Alzheimer's.
DIAGNOSTIC ACCURACY AND CONFIDENCE IN THE CLINICAL DETECTION OF COGNITIVE IMPAIRMENT IN EARLY-STAGE PARKINSON’S DISEASE  Kathryn A. Wyman-Chick, Phillip.
Relationship between Microstructural Degeneration of the Corpus Callosum, White Matter Hyperintensities, and Motor Function in Cognitively Intact Elderly 
Hilkka Liedes, Jyrki Lötjönen, Gerald P. Novak, Mark Forrest Gordon 
Comparison of accelerated and nonaccelerated MRI in ADNI: Effects on measures of brain and ventricular volumes and rates of atrophy  Kelvin Leung, Casper.
Balpreet Matharu, Nick Spencer, Franklyn Howe, Brian Austen 
Early pathologic amyloid induces hypersynchrony of BOLD resting-state networks in transgenic mice and provides an early therapeutic window before amyloid.
A SYSTEMATIC REVIEW AND META-ANALYSIS COMPARING QUALITY-OF-LIFE RATINGS FROM FAMILY AND PAID CAREGIVERS OF PEOPLE WITH DEMENTIA RESIDING IN CARE HOMES 
Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Trajectory of multi-dimensional caregiving burden in chinese informal caregivers for dementia: Evidence from exploratory and confirmatory factor analysis.
Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Volume 1, Issue 3, Pages (November 2015)
Localization of Hippocampal atrophy in Alzheimer's disease
INVESTIGATION OF 99MTC-LABELED CLIOQUINOL DERIVATIVE ON AMYLOID PLAQUE SPECIFICITY BY USING AN ANIMAL MODEL OF ALZHEIMER'S DISEASE  Ayfer Yurt KIlçar,
Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Christine Bredfeldt, Kristen Rice, Lisa Alecxih 
Comparison of tract-based spatial statistics and ROI-based approach in analyzing the white matter integrity in the elderly  Huali Wang, Daniel Chang,
KETOGENIC DIET EFFECTS ON BRAIN KETONE METABOLISM AND ALZHEIMER'S DISEASE CSF BIOMARKERS  Suzanne Craft, Bryan J. Neth, Akiva Mintz, Kiran Sai, Nora Shively,
Application of Resource Utilization in Dementia (RUD) instrument in a global setting  Anders Wimo, Anders Gustavsson, Linus Jönsson, Bengt Winblad, Ming-Ann.
New tools for the diagnosis of Alzheimer's disease by MRI:
Biphasic Alteration of the Inhibitory Synapse Scaffold Protein Gephyrin in Early and Late Stages of an Alzheimer Disease Model  Eva Kiss, Karin Gorgas,
The global prevalence of dementia: A systematic review and metaanalysis  Martin Prince, Renata Bryce, Emiliano Albanese, Anders Wimo, Wagner Ribeiro, Cleusa.
HYPERGLYCEMIA: PREDISPOSITION FOR MICROEMBOLI, STROKE, AND WHITE MATTER CHANGES  Leila Parand, Saif Bushnaq, Yue Wang, Lenora Mathes, Dinesh Jillella,
Marjolein Bulk, Linda van der Graaf, Walid M
Cerebral amyloid angiopathy, neurodegeneration, and dementia in a population-based study on the very elderly Finns (Vantaa 85+)  Maarit Tanskanen, Mira.
Colin Groot, Chris W. J. van der Weijden, Wiesje M
Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Japanese brain bank network for neuroscience research
DUAL FUNCTIONAL NANOPARTICLES FOR M1 ACETYLCHOLINE RECEPTOR SELECTIVE ALLOSTERIC POTENTIATOR TO TARGET AMYLOID PLAQUES IN THE BRAIN OF STREPTOZOTOCIN-INDUCED.
Fig. 2. Increased Aβ plaque load in 16-month-old APP/PS1;C3 KO mice.
Ming Hong Shen, Paulina Samsel, Louise L
Volume 355, Issue 9202, (February 2000)
The incretin hormones glucagonlike peptide 1 and glucose-dependent insulinotropic polypeptide are neuroprotective in mouse models of Alzheimer's disease 
ApoE4 Accelerates Early Seeding of Amyloid Pathology
Ara S. Khachaturian, David P
Volume 78, Issue 4, Pages (May 2013)
Prevalence and incidence of clinically diagnosed Alzheimer's disease dementia from 1994 to 2012 in a population study  Kumar B. Rajan, Jennifer Weuve,
In vivo tau imaging: Obstacles and progress
Application of Resource Utilization in Dementia (RUD) instrument in a global setting  Anders Wimo, Anders Gustavsson, Linus Jönsson, Bengt Winblad, Ming-Ann.
A nonhuman primate model of early Alzheimer's disease pathologic change: Implications for disease pathogenesis  Caitlin S. Latimer, Carol A. Shively,
Volume 372, Issue 9634, Pages (July 2008)
Volume 64, Issue 5, Pages (December 2009)
Prevalence and incidence of clinically diagnosed Alzheimer's disease dementia from 1994 to 2012 in a population study  Kumar B. Rajan, Jennifer Weuve,
Volume 74, Issue 6, Pages (September 2008)
LIFESPAN OF ONE FOCUSED ULTRASOUND MEDIATED BLOOD-BRAIN BARRIER TREATMENT IN A MOUSE MODEL OF ALZHEIMER'S DISEASE  Charissa Poon, Kullervo Hynynen  Alzheimer's.
Summary of the evidence on modifiable risk factors for cognitive decline and dementia: A population-based perspective  Matthew Baumgart, Heather M. Snyder,
Volume 71, Issue 5, Pages (September 2011)
Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: Phase 3 study  Osama Sabri, Marwan N. Sabbagh, John Seibyl, Henryk Barthel,
Shruti Mishra, Brian Andrew Gordon, Karl A
Comparison of visual and quantitative florbetapir-PET reads in subjects with early Alzheimer's disease for assessing amyloid burden  Bradley Wyman, Yahong.
Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Linus Jönsson, Pei-Jung Lin, Ara S. Khachaturian 
Added value of 11C-PiB-PET imaging in the diagnosis of Alzheimer's disease  Kristian Frederiksen, Anne-Mette Hejl, Ian Law, Steen Hasselbalch, Gunhild.
Mark D. Meadowcroft, Douglas G. Peters, Carson J
Volume 49, Issue 4, Pages (February 2006)
Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Cerebral hypoperfusion is not associated with an increase in amyloid β pathology in middle-aged or elderly people  Oskar Hansson, Sebastian Palmqvist,
DIFFERENCES IN ANALYTICAL SELECTIVITY OF β-AMYLOID (1-42) IMMUNOASSAYS EXPLAIN DISCORDANT RESULTS IN STUDY COMPARISONS  Hugo Marcel Vanderstichele, Emeric.
Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Alzheimer's Association towards Guidelines for Dementia Care Practice: Recommendations with emphasis on high-quality, person-centered care in long-term.
Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Racial and ethnic estimates of Alzheimer's disease and related dementias in the United States (2015–2060) in adults aged ≥65 years  Kevin A. Matthews,
A nonhuman primate model of early Alzheimer's disease pathologic change: Implications for disease pathogenesis  Caitlin S. Latimer, Carol A. Shively,
Automated detection of beta-amyloid–related cortical and subcortical signal changes in a transgenic model of Alzheimer's disease using high-field MRI 
Increased risk for dementia both before and after stroke: A population-based study in women followed over 44 years  Xinxin Guo, Svante Östling, Silke.
Bistra Iordanova, Matthew C. Murphy, William E. Klunk, Alberto L
Pioglitazone induces the clearance of amyloid in APP/PS1 mice.
Fig. 2. SUS reduces Aβ plaques in an AD mouse model.
Presentation transcript:

Alzheimer's & Dementia: The Journal of the Alzheimer's Association In vivo Gd-staining MRI reveals efficacy of anti-beta-amyloid immunotherapy after longitudinal study in a transgenic mouse model of Alzheimer's disease  Mathieu Santin, Thomas Debeir, Thierry Delzescaux, Anne-Sophie Hérard, Caroline Cohen, Laurent Pradier, Thomas Rooney, Marc Dhenain  Alzheimer's & Dementia: The Journal of the Alzheimer's Association  Volume 9, Issue 4, (July 2013) DOI: 10.1016/j.jalz.2013.05.020 Copyright © 2013 Terms and Conditions

Fig. 1 Longitudinal follow-up of amyloid plaque load in APP/PS1 mice. Left – ln vivo ICV-Gd-staining MRI of a control APP/PS1 mouse at 5.5 month-old. White circles are ROIs where amyloid load was quantified. Spots identified as plaques are visible within the cortex and drawn in white into the ROIs. Center – MRI of the same APP/PS1 mouse at the age of 8.5 months. Right - Comparison of amyloid plaque load measured on APP/PS1 mice treated with the anti-Aβ antibody or with the control antibody. Error bars stand for standard error of the mean. Alzheimer's & Dementia: The Journal of the Alzheimer's Association 2013 9, DOI: (10.1016/j.jalz.2013.05.020) Copyright © 2013 Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.